Search

Author/Creator Bourliere, M.

1. Bulevirtide monotherapy is safe and well tolerated in patients with chronic hepatitis D (CHD): An integrated safety analysis of 48-week data. (March 2023)

Authors:
Asselah, T.; Lampertico, P.; Aleman, S.; Bourliere, M.; Streinu-Cercel, A.; Bogomolov, P.; Morozov, V.; Stepanova, T.; Lazar, S.; Suri, V.; Manuilov, D.; Mercier, R.C.; Tseng, S.; Ye, L.; Flaherty, J.F.; Osinusi, A.; Brunetto, M.; Wedemeyer, H.
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 1
Page Start:
S74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Issue 11 (9th October 2017)

Authors:
Pol, S.; Haour, G.; Fontaine, H.; Dorival, C.; Petrov‐Sanchez, V.; Bourliere, M.; Capeau, J.; Carrieri, P.; Larrey, D.; Larsen, C.; Marcellin, P.; Pawlostky, J.‐M.; Nahon, P.; Zoulim, F.; Cacoub, P.; de Ledinghen, V.; Mathurin, P.; Negro, F.; Pageaux, G.‐P.; Yazdanpanah, Y.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 11/12(2017)
Page Start:
1054
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗